Premium
Cognitive and linguistic abnormalities in benign childhood epilepsy with centrotemporal spikes
Author(s) -
Verrotti A,
D’Egidio C,
Agostinelli S,
Parisi P,
Chiarelli F,
Coppola G
Publication year - 2011
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2011.02159.x
Subject(s) - boston naming test , rolandic epilepsy , epilepsy , wechsler adult intelligence scale , audiology , medicine , neuropsychology , cognition , peabody picture vocabulary test , pediatrics , wechsler intelligence scale for children , neuropsychological assessment , psychiatry
Aim: To assess the cognitive function and language ability in children with benign partial epilepsy with centrotemporal spikes. Methods: Twenty‐five patients with benign partial epilepsy with centrotemporal spikes were included. They were divided into two subgroups. Group I: 10 patients with rolandic focus who were not treated. Group II: 15 patients with rolandic focus receiving treatment. A third Group of 12 healthy subjects have been studied. All children underwent standardized neuropsychological testing: electroencephalogram recording, Wechsler Intelligence Scale for Children‐revised, Peabody Picture Vocabulary Test‐III (PPVT‐III) and Boston Naming Test (BNT), both during active disease (T1) and 2 years after recovery from epilepsy (T2). Results: At T1 evaluation, no significant differences in group I and II patients about general intelligence, when compared with controls, were found. Group I and II patients were impaired with respect to controls in the receptive and expressive vocabulary evaluated with PCVT‐III and BNT, respectively. At T2 evaluation, group I and II patients showed a normalization of the language abnormalities. Conclusion: Deficits of speech‐related abilities can be detected in children with this type of epilepsy: these dysfunctions seem to be independent of the effects of antiepileptic treatment and are reversible after remission of epilepsy.